Postoperative atrial fibrillation

1. Empagliflozin has no effect on postoperative atrial fibrillation in humans (20.0% vs. 39.0%, p = 0.088).

   Human trialheart valve surgeryoral10 mg dailyfrom 3 days pre-op to 3 days post-opn = 81

   Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after heart valve surgery: a double-blind, randomized, placebo-controlled trial

   Indian journal of thoracic and cardiovascular surgery·22 Jul 2026

More on Empagliflozin

1. Blood count-derived immunosenescence biomarkers have no effect on postoperative atrial fibrillation in humans (P = .357).

   Humansisolated CABGn = 9,046

   Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting

   JTCVS open·9 Mar 2026

More on Blood count-derived immunosenescence biomarkers

1. INTERLEUKIN-17 predicts postoperative atrial fibrillation in humans.

   Humanspostoperative AF in the Fuwai Hospital cohort

   Single-Nucleus and Multiomics Profiling of Epicardial Adipose Tissue in Atrial Fibrillation Reveals Novel Mechanisms and Translational Biomarkers

   Journal of the American Heart Association·27 Aug 2026

More on INTERLEUKIN-17